Bovilis BVD

国: ニュージーランド

言語: 英語

ソース: Ministry for Primary Industries

即購入

製品の特徴 製品の特徴 (SPC)
01-10-2023
公開評価報告書 公開評価報告書 (PAR)
01-10-2018

有効成分:

bovine viral diarrhoea virus (inactivated)

から入手可能:

Schering-Plough Animal Health Limited

INN(国際名):

bovine viral diarrhoea virus (inactivated)

構図:

bovine viral diarrhoea virus (inactivated) 0 vaccine

治療領域:

Vaccine

認証ステータス:

ACVM Registered

承認日:

2001-11-15

製品の特徴

                                BOVILIS BVD
10 mL, 20 mL, 50 mL and 100 mL – Leaflet, Carton and Label
A008237
Page 1 of 10
BOVILIS BVD
06-Oct-23
Leaflet
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
BOVILIS
®
BVD
VACCINE CONTAINING INACTIVATED BVDV ANTIGEN FOR THE ACTIVE
IMMUNISATION OF CATTLE
AGAINST BOVINE VIRAL DIARRHOEA VIRUS (BVDV) AND, IN COWS AND HEIFERS,
FOR PROTECTION
AGAINST TRANSPLACENTAL INFECTION OF THE FETUS WITH BVDV.
Bovilis BVD contains inactivated antigen of cytopathogenic BVDV strain
C-86.
READ ENTIRE LEAFLET BEFORE USE.
DOSAGE AND ADMINISTRATION
Dose = 2 mL by intramuscular or subcutaneous injection into the
anterior third of the neck.
Allow product to reach ambient temperature and shake bottle well
before use. Ensure
vaccinator gun delivers correct dose. Use sterile equipment and change
needles frequently.
Vaccinate only healthy, clean and dry animals.
RECOMMENDED VACCINATION PROGRAMME
PRIMARY VACCINATION
The primary course consists of a sensitiser dose (2 mL) followed by a
booster dose (2 mL)
administered between 4 weeks to 6 months later.
ANNUAL (BOOSTER) VACCINATION
ALL CLASSES OF CATTLE (INCLUDING BULLS)
An annual booster dose (2 mL) should be given every 12 months to
maintain immunity and
provide fetal protection.
BREEDING CATTLE
Good practice is to administer booster vaccination no less than but
close to 4 weeks before the
start of mating to ensure fetal protection in early gestation.
CALVES
Calves can be vaccinated from 4 months of age (all classes of cattle).
This is to ensure that any
maternally derived antibodies do not reduce the effectiveness of the
vaccine.
FETAL PROTECTION
Following a third dose (annual vaccination) Bovilis BVD provides 12
months fetal protection.
ADVERSE REACTIONS
A slight swelling may be observed at the site of vaccination for 1 to
2 weeks. Occasionally,
transient mild pyrexia may also occur.
ADDITIONAL INFORMATION
Field data has shown that Bovilis BVD vaccine has no adverse effect on
milk production.
This product is safe for use in pregnant cows.
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索

ドキュメントの履歴を表示する